NCT05042856

To Evaluate IOL Position, Clinical Outcome of PanOptix in High Myopic Cataract Patients

A Prospective, Single Center Study to Evaluate IOL Position, Clinical Outcome of PanOptix in High Myopic Cataract Patients

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Wenzhou Medical University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To evaluate IOL position, clinical outcome of PanOptix in high myopic cataract patients

Detailed description

A prospective, single center study to evaluate IOL position, clinical outcome of PanOptix in high myopic cataract patients. The objective of this study to investigate the refractive and visual performance of PanOptix and explore their correlation with ELP change, capsular bending formation, IOL tilt/decentration in high myopic cataract patients. PanOptix IOL provides good refractive outcomes and visual quality because of few ELP change, fast capsular bending formation and few tilt and decentration in high myopic cataract patients.

Conditions

• Cataract
• High Myopia

Interventions

Type	Name	Description
PROCEDURE	PanOptix IOL implantation	All the patients will be bilaterally implanted with PanOptix IOL，one eye will be randomized selected for monocular analysis of each patient.

Timeline

• Start date: 2021-10-01
• Primary completion: 2022-09-30
• Completion: 2022-09-30
• First posted: 2021-09-13
• Last updated: 2021-09-21

Locations

1 site across 1 country: China